Status:
COMPLETED
Pregabalin In Partial Seizures: An Open-Label, International, Multicenter Add-On Therapy Trial.
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Seizures
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To assess the clinical improvement (change in seizure frequency), safety and tolerability of patients with partial seizures following adjunctive therapy of pregabalin BID in addition to existing stand...
Eligibility Criteria
Inclusion
- Male and female subjects with a diagnosis of partial epilepsy.
- 18 years and older.
Exclusion
- Having a treatable cause of seizure.
- Having a progressive neurological or systemic disorder
Key Trial Info
Start Date :
November 1 2004
Trial Type :
INTERVENTIONAL
End Date :
May 1 2006
Estimated Enrollment :
540 Patients enrolled
Trial Details
Trial ID
NCT00141427
Start Date
November 1 2004
End Date
May 1 2006
Last Update
January 25 2021
Active Locations (57)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Bruges, Belgium, 8000
2
Pfizer Investigational Site
Brussels, Belgium, B-1070
3
Pfizer Investigational Site
Duffel, Belgium, 2570
4
Pfizer Investigational Site
Ghent, Belgium, 9000